Research graph
References from Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · External reference
Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification
10.1093/annonc/mdm267 · 2007 · External reference
Pattern and dynamics of distant metastases in metastatic colorectal cancer
10.1159/000454687 · 2017 · External reference
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
10.1016/s1470-2045(11)70097-3 · 2011 · External reference
Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study
10.1002/bjs5.50299 · 2020 · External reference
Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis
10.1002/cam4.2673 · 2020 · External reference
Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis
10.1016/j.canep.2015.07.009 · 2015 · External reference
Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
10.1067/j.cpsurg.2018.08.004 · 2018 · External reference
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
10.1093/annonc/mdw235 · 2016 · External reference
NCCN guidelines for rectal cancer
2020 · External reference
NCCN guidelines for colon cancer
2020 · External reference
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
10.1093/annonc/mdx738 · 2018 · External reference
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
10.1016/s1470-2045(14)70330-4 · 2014 · External reference
Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial
10.1001/jama.2017.7105 · 2017 · External reference
Variation in the use of resection for colorectal cancer liver metastases
10.1097/sla.0000000000003534 · 2019 · External reference
Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
10.1007/s10585-015-9719-0 · 2015 · External reference
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases
10.1186/s12885-020-6710-1 · 2020 · External reference
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data
10.1002/ijc.33200 · 2021 · External reference
Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance
10.1002/bjs.11609 · 2020 · External reference
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
10.1016/s1470-2045(09)70330-4 · 2010 · External reference
Assessing resectability of colorectal liver metastases: how do different subspecialties interpret the same data?
10.1503/cjs.014616 · 2018 · External reference
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3
10.1016/j.ejca.2017.10.028 · 2018 · External reference
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: supported by the ARCAD Group
10.1016/j.ejca.2018.05.010 · 2018 · External reference
Challenges of guarantee-time bias
10.1200/jco.2013.49.5283 · 2013 · External reference
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
10.1186/1471-2407-11-438 · 2011 · External reference
Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial
10.1186/s13063-019-3837-y · 2019 · External reference
Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed
10.1111/codi.15113 · 2020 · External reference
Effect of specialist decision-making on treatment strategies for colorectal liver metastases
10.1002/bjs.8835 · 2012 · External reference
Outcomes of resectability assessment of the Dutch colorectal cancer group liver metastases expert panel
10.1016/j.jamcollsurg.2019.08.1445 · 2019 · External reference
The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer
10.1016/j.ejca.2018.07.012 · 2018 · External reference
Debulking surgery for colorectal liver metastases: foolish or chance?
10.1016/j.suronc.2020.02.008 · 2020 · External reference
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival
10.1097/01.sla.0000141198.92114.f6 · 2004 · External reference
Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases
10.1186/s12957-016-0807-7 · 2016 · External reference
Role of repeat resection in patients with metastatic colorectal cancer: a multicenter retrospective study
10.1097/dcr.0000000000001311 · 2019 · External reference
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
10.1002/bjs.8667 · 2012 · External reference
Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience
10.1155/2013/727095 · 2013 · External reference
Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases
10.1245/s10434-012-2382-7 · 2012 · External reference
Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer
2017 · External reference
Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients
10.1002/cncr.24527 · 2009 · External reference
